MicroRNAs in the biology and diagnosis of cholangiocarcinoma

Seminars in Liver Disease

Volumn 35, Issue 1, 2015, Pages 55-62

  Piontek, Klaus ^a   Selaru, Florin M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biomarkers; cholangiocarcinoma; dysregulation; microRNA; therapeutic targets

Indexed keywords

BETA CATENIN; MICRORNA; TUMOR MARKER;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; BIOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; EARLY DIAGNOSIS; EPIGENETICS; HEDGEHOG; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; VALIDATION STUDY; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; GENETICS; INTRAHEPATIC BILE DUCT; METABOLISM;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 84928565019     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0034-1397349     Document Type: Article

References (88)

1. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell: 2003; 113 6 673 676
2. Mlynarczyk S. K., Panning B. X inactivation: Tsix and Xist as yin and yang. Curr Biol: 2000; 10 24 R899 R903
3. Lai E. C. microRNAs: runts of the genome assert themselves. Curr Biol: 2003; 13 23 R925 R936
4. Lee R. C., Feinbaum R. L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell: 1993; 75 5 843 854
5. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell: 1993; 75 5 855 862
6. Carrington J. C., Ambros V. Role of microRNAs in plant and animal development. Science: 2003; 301 5631 336 338
7. Lee Y., Kim M., Han J., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J: 2004; 23 20 4051 4060
8. Cai X., Hagedorn C. H., Cullen B. R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA: 2004; 10 12 1957 1966
9. Rodriguez A., Griffiths-Jones S., Ashurst J. L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res: 2004; 14 (10A): 1902 1910
10. Denli A. M., Tops B. B., Plasterk R. H., Ketting R. F., Hannon G. J. Processing of primary microRNAs by the microprocessor complex. Nature: 2004; 432 7014 231 235
11. Lee Y., Ahn C., Han J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature: 2003; 425 6956 415 419
12. Gregory R. I., Yan K. P., Amuthan G., et al. The microprocessor complex mediates the genesis of microRNAs. Nature: 2004; 432 7014 235 240
13. Lund E., Güttinger S., Calado A., Dahlberg J. E., Kutay U. Nuclear export of microRNA precursors. Science: 2004; 303 5654 95 98
14. Okada C., Yamashita E., Lee S. J., et al. A high-resolution structure of the pre-microRNA nuclear export machinery. Science: 2009; 326 5957 1275 1279
15. Bernstein E., Caudy A. A., Hammond S. M., Hannon G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature: 2001; 409 6818 363 366
16. Grishok A., Pasquinelli A. E., Conte D., et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell: 2001; 106 1 23 34
17. Hutvágner G., McLachlan J., Pasquinelli A. E., Bálint E., Tuschl T., Zamore P. D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science: 2001; 293 5531 834 838
18. Ketting R. F., Fischer S. E., Bernstein E., Sijen T., Hannon G. J., Plasterk R. H. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev: 2001; 15 20 2654 2659
19. Czech B., Hannon G. J. Small RNA sorting: matchmaking for Argonautes. Nat Rev Genet: 2011; 12 1 19 31
20. Chendrimada T. P., Gregory R. I., Kumaraswamy E., et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature: 2005; 436 7051 740 744
21. Haase A. D., Jaskiewicz L., Zhang H., et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep: 2005; 6 10 961 967
22. Lee Y., Hur I., Park S. Y., Kim Y. K., Suh M. R., Kim V. N. The role of PACT in the RNA silencing pathway. EMBO J: 2006; 25 3 522 532
23. Grimson A., Farh K. K., Johnston W. K., Garrett-Engele P., Lim L. P., Bartel D. P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell: 2007; 27 1 91 105
24. Bartel D. P. MicroRNAs: target recognition and regulatory functions. Cell: 2009; 136 2 215 233
25. Friedman R. C., Farh K. K., Burge C. B., Bartel D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res: 2009; 19 1 92 105
26. Karginov F. V., Cheloufi S., Chong M. M., Stark A., Smith A. D., Hannon G. J. Diverse endonucleolytic cleavage sites in the mammalian transcriptome depend upon microRNAs, Drosha, and additional nucleases. Mol Cell: 2010; 38 6 781 788
27. Baek D., Villén J., Shin C., Camargo F. D., Gygi S. P., Bartel D. P. The impact of microRNAs on protein output. Nature: 2008; 455 7209 64 71
28. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature: 2008; 455 7209 58 63
29. Hendrickson D. G., Hogan D. J., McCullough H. L., et al. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol: 2009; 7 11 e1000238
30. Mullokandov G., Baccarini A., Ruzo A., et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods: 2012; 9 8 840 846
31. Kedde M., Strasser M. J., Boldajipour B., et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell: 2007; 131 7 1273 1286
32. Bhattacharyya S. N., Habermacher R., Martine U., Closs E. I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell: 2006; 125 6 1111 1124
33. Kim H. H., Kuwano Y., Srikantan S., Lee E. K., Martindale J. L., Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev: 2009; 23 15 1743 1748
34. Pasquinelli A. E., Ruvkun G. Control of developmental timing by microRNAs and their targets. Annu Rev Cell Dev Biol: 2002; 18 495 513
35. Farazi T. A., Hoell J. I., Morozov P., Tuschl T. MicroRNAs in human cancer. Adv Exp Med Biol: 2013; 774 1 20
36. Hummel R., Hussey D. J., Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer: 2010; 46 2 298 311
37. Calin G. A., Liu C. G., Sevignani C., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A: 2004; 101 32 11755 11760
38. Schetter A. J., Leung S. Y., Sohn J. J., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA: 2008; 299 4 425 436
39. Lu J., Getz G., Miska E. A., et al. MicroRNA expression profiles classify human cancers. Nature: 2005; 435 7043 834 838
40. Hatley M. E., Patrick D. M., Garcia M. R., et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell: 2010; 18 3 282 293
41. Medina P. P., Nolde M., Slack F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature: 2010; 467 7311 86 90
42. Costinean S., Zanesi N., Pekarsky Y., et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A: 2006; 103 18 7024 7029
43. O'Connell R. M., Rao D. S., Chaudhuri A. A., et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med: 2008; 205 3 585 594
44. Tagawa H., Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia: 2005; 19 11 2013 2016
45. He L., Thomson J. M., Hemann M. T., et al. A microRNA polycistron as a potential human oncogene. Nature: 2005; 435 7043 828 833
46. Kumar M. S., Erkeland S. J., Pester R. E., et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A: 2008; 105 10 3903 3908
47. Meng F., Henson R., Lang M., et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology: 2006; 130 7 2113 2129
48. Okamoto K., Miyoshi K., Murawaki Y. miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells. PLoS ONE: 2013; 8 10 e77623
49. Meng F., Henson R., Wehbe-Janek H., Smith H., Ueno Y., Patel T. The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem: 2007; 282 11 8256 8264
50. Meng F., Wehbe-Janek H., Henson R., Smith H., Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene: 2008; 27 3 378 386
51. Zhang J., Han C., Zhu H., Song K., Wu T. miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF). Am J Pathol: 2013; 182 5 1629 1639
52. Lu L., Byrnes K., Han C., Wang Y., Wu T. miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth. Mol Cancer Res: 2014; 12 6 890 900
53. Chusorn P., Namwat N., Loilome W., et al. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Tumour Biol: 2013; 34 3 1579 1588
54. He Q., Cai L., Shuai L., et al. Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21. Mol Carcinog: 2013; 52 4 286 296
55. Gruber J. J., Zatechka D. S., Sabin L. R., et al. Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation. Cell: 2009; 138 2 328 339
56. Iwaki J., Kikuchi K., Mizuguchi Y., et al. MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line. PLoS ONE: 2013; 8 7 e69496
57. Liu X., Jiang L., Wang A., Yu J., Shi F., Zhou X. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett: 2009; 286 2 217 222
58. Wang Q., Tang H., Yin S., Dong C. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep: 2013; 29 5 2046 2052
59. Liu C. Z., Liu W., Zheng Y., et al. PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma. Chin Med Sci J: 2012; 27 2 65 72
60. Mott J. L., Kobayashi S., Bronk S. F., Gores G. J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene: 2007; 26 42 6133 6140
61. Mott J. L., Kurita S., Cazanave S. C., Bronk S. F., Werneburg N. W., Fernandez-Zapico M. E. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem: 2010; 110 5 1155 1164
62. Chen L., Yan H. X., Yang W., et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol: 2009; 50 2 358 369
63. Selaru F. M., Olaru A. V., Kan T., et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology: 2009; 49 5 1595 1601
64. Peng F., Jiang J., Yu Y., et al. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. Br J Cancer: 2013; 109 12 3092 3104
65. Pasini D., Bracken A. P., Jensen M. R., Lazzerini Denchi E., Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J: 2004; 23 20 4061 4071
66. Olaru A. V., Ghiaur G., Yamanaka S., et al. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology: 2011; 54 6 2089 2098
67. Zhong X. Y., Yu J. H., Zhang W. G., et al. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene: 2012; 493 1 44 51
68. Hu C., Huang F., Deng G., Nie W., Huang W., Zeng X. miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1. Exp Ther Med: 2013; 6 5 1265 1270
69. Kunkeaw N., Jeon S. H., Lee K., et al. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene: 2013; 32 32 3722 3731
70. An F., Yamanaka S., Allen S., et al. Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch. PLoS ONE: 2012; 7 10 e45606
71. Chen Y., Luo J., Tian R., Sun H., Zou S. miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinoma. Dig Dis Sci: 2011; 56 6 1693 1701
72. Chen Y., Gao W., Luo J., Tian R., Sun H., Zou S. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma. Oncol Rep: 2011; 25 2 443 451
73. Chen Y. J., Luo J., Yang G. Y., Yang K., Wen S. Q., Zou S. Q. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma. World J Gastroenterol: 2012; 18 29 3849 3861
74. Zeng B., Li Z., Chen R., et al. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3. FEBS Lett: 2012; 586 19 3271 3278
75. Foreman K. W., Brown M., Park F., et al. Structural and functional profiling of the human histone methyltransferase SMYD3. PLoS ONE: 2011; 6 7 e22290
76. Li B., Han Q., Zhu Y., Yu Y., Wang J., Jiang X. Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. FEBS J: 2012; 279 13 2393 2398
77. Oishi N., Kumar M. R., Roessler S., et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology: 2012; 56 5 1792 1803
78. Qiu Y. H., Wei Y. P., Shen N. J., et al. miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells. Cell Physiol Biochem: 2013; 32 5 1331 1341
79. Razumilava N., Bronk S. F., Smoot R. L., et al. miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology: 2012; 55 2 465 475
80. Zhang J., Han C., Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin. Gastroenterology: 2012; 143 1 246 56.e8
81. Janpipatkul K., Suksen K., Borwornpinyo S., et al. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration. Cell Signal: 2014; 26 8 1668 1679
82. Kawahigashi Y., Mishima T., Mizuguchi Y., et al. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J Nippon Med Sch: 2009; 76 4 188 197
83. Chen X., Chen J., Liu X., Guo Z., Sun X., Zhang J. The real-time dynamic monitoring of microRNA function in cholangiocarcinoma. PLoS ONE: 2014; 9 6 e99431
84. Karakatsanis A., Papaconstantinou I., Gazouli M., Lyberopoulou A., Polymeneas G., Voros D. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog: 2013; 52 4 297 303
85. McNally M. E., Collins A., Wojcik S. E., et al. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford): 2013; 15 4 260 264
86. Collins A. L., Wojcik S., Liu J., et al. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Ann Surg Oncol: 2014; 21 1 133 138
87. Li L., Masica D., Ishida M., et al. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology: 2014; 60 3 896 907
88. Jiao Y., Pawlik T. M., Anders R. A., et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet: 2013; 45 12 1470 1473